BDX103

N/A

Report date: 2024/05/08 10:19:52

Base Information

Drug NameBDX103
Drug Alias NameBDX-103CRES-103
ClassificationBiologics
Mechanisms of ActionMyelin proteins stimulants
TargetsMyelin proteins
Therapy Area/IndicationsPolyradiculoneuropathy, Chronic Inflammatory Demyelinating
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCresence AS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioasis Technologies Inc
Active IndicationsN/A
Inactive IndicationsPolyradiculoneuropathy, Chronic Inflammatory Demyelinating

Other Information

ATC CodeN/A
Related LinksN/A